The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.

Read more about BAP

Antidepressants and Suicide

Prof Carmine Pariante attended House of Commons Health Select Committee regarding antidepressants and suicide
Read More

Metabolic Guidelines Article

Article on the recent metabolic guidelines by Peter Haddad, Gavin Reynolds and Stephen Cooper
Read More

Dementia Guidelines Meeting

Clinical Practice with Anti-Dementia Drugs: Updated Guidelines from the BAP, 19th January 2017
Read More

Fundamentals Wins BMA Award

Fundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Read More

Fundamentals of Clinical Psychopharmacology

Buy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
Read More

Online CPD Resource

RCPsych Online CPD Subscribers get a discount on the BAP Online Resource
Read More

New world order: Brexit, drugs and research

Letter to House of Commons Science and Technology Committee
Read More

The Ten Secrets of Success in Science

View Professor Trevor Robbins presenting his top tips
Read More

Neuroscience-based Nomenclature (NbN) for JoP

Journal of Psychopharmacology chosen to trial new NbN
Read More

Ketamine Scheduling

BAP endorses the Fact Sheet on Ketamine Scheduling
Read More

Benefits of BAP membership include:

  • FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
  • Reduced registration fees for the annual Summer Meeting.
  • Half price subscription to the Online CPD Resource.
  • Eligibility for prizes and awards.
  • Student bursaries for the BAP Summer Meeting and international conferences.
  • Reduced registration fees for selected partner association events.
  • 50% OFF Royal Society of Biology membership (Read more)
  • BAP Newsletter.
  • Voting for BAP Officers and Council (full members only).
  • Being part of one of the largest national psychopharmacology associations in the world.

Meetings and Events

External Event BAP Session BAP Event BAP Stand

All Events

19th January 2017 Clinical Practice with Anti-Dementia Drugs: Updated Guidelines from the BAP Hallam Conference Centre, 44 Hallam Street London
26th January 2017 Anxiety Disorders The Bristol Hotel, Prince Street, Bristol
16th March 2017 Child and Adolescent Psychopharmacology Park Plaza Hotel, Maid Marian Way, Nottingham

Clinical Certificate | Masterclasses | Non-Clinical Certificate

Articles

Why isn’t there a gene for depression?
By Sarah Bailey
Posted on 14th November 2016

A DNA sequence or events?Dr Sarah Bailey, Senior Lecturer in Pharmacy and Pharmacology, University of Bath. Depression is sometimes categorised as a mental, rather than a...


Donepezil and rhabdomyolysis – are you aware?
By Bharathi Balasundaram
Posted on 14th November 2016

donepezil-300x223Bharathi Balasundaram is a Consultant in Psycho Geriatrics, Changi General Hospital, Singapore. Acetylcholinesterase inhibitors (Donepezil, Rivastigmine and Galantamine) are used as cognitive enhancing agents in the management...


More Fish – Better Emotion and Better Attention
By Jane Pei-Chen Chang
Posted on 3rd November 2016

omega3-capsules-fish-shape“Take Omega-3s, they are good for your mood…” “DHA is good for the developing brain…” So what are omega-3? We have seen them at nutritional...


See more articles

Media

Hip Hop Psych (Akeem Sule and Becky Inkster)
Kanye West's travails help hip-hop open up on mental health
HipHopPsych was interviewed in guardian following Kanye West's hospitalisation
25th November 2016

Julia Gottwald
Teens Reject Junk Food When Healthy Eating is Framed as Rebellion
Julia wrote an article for the British Psychological Society Research Digest about a new health intervention to make teenagers eat less junk food
20th October 2016

Hip Hop Psych (Akeem Sule and Becky Inkster)
In The Battle Against Depression, Hip-Hop Has Healing Powers
Hip Hop Psych was mentioned in Vibe, a well known hiphop magazine
16th October 2016

See more media

News

Professor David Nutt receives honorary degree from Bath University
8th December 2016

BAP warmly congratulates Professor David Nutt, who has been awarded Degree of Doctor of Laws, honoris causa, from Bath University.
Read More
Antidepressants and Suicide
2nd December 2016

Professor Carmine Pariante, a member of the BAP Council, recently attended the House of Commons to give expert input to the Health Select Committee regarding antidepressants and suicide
Read more
Fundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
12th September 2016

The Fundamentals of Clinical Psychopharmacology has won the BMA Medical Book Award in Psychiatry
Read more
New world order: Brexit, drugs and research
12th August 2016

Oliver Howes wrote to House of Commons Science and Technology Committee to raise issues on behalf of the BAP following the Brexit vote.
Read BAP letter to Nicola Blackwood

See more news

Twitter

Journal of Psychopharmacology

Most recent articles:

Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future
By Nutt, D.
Published on 1st December 2016

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
By Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., Su, Z., Corby, P., Schmidt, B. L.
Published on 1st December 2016

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
By Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., Klinedinst, M. A.
Published on 1st December 2016

Journal Website


Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.